94TH GENERAL ASSEMBLY
State of Illinois
2005 and 2006
SB1517


 
Introduced 2/23/2005, by Sen. Jacqueline Y. Collins - Miguel del Valle
 
SYNOPSIS AS INTRODUCED:
 		













20 ILCS 2310/2310-367 new










    Amends the Department of Public Health Powers and Duties Law. Provides that any entity conducting a clinical drug trial on a human person in this State  must register with the Department. Sets forth certain minimum requirements for the registration. Provides that the information so gathered  shall be collected in a clinical trials data bank  administered by the Department.  Requires the Department to publish aggregates of the clinical trials data collected, at least annually, and with personal identifiers redacted.  Sets forth the purposes for the publication of clinical trials data and provides that the Department shall take all steps necessary under State and federal law to protect patient confidentiality. Provides that the Department shall adopt rules  as necessary to implement the requirements.
















LRB094 08104 RSP 38289 b

















FISCAL NOTE ACT MAY APPLY
















 


 


A BILL FOR









 











SB1517

LRB094 08104 RSP 38289 b






1
    AN ACT concerning State government.

 
2
    Be it enacted by the People of the State of Illinois,
 
3
represented in the General Assembly:


 
4
    Section 5. The Department of Public Health Powers and 
5
Duties Law of the
Civil Administrative Code of Illinois is 
6
amended  by adding Section 2310-367 as follows:
 
7
    (20 ILCS 2310/2310-367  new)
8
    Sec. 2310-367. Clinical drug trial registry; data bank. The 
9
Department shall require that every hospital, laboratory, 
10
person, or facility conducting a clinical drug trial on a human 
11
person in this State  must register with the Department. The 
12
Department shall specify the form and content of the 
13
registration, which shall at a minimum require the  entity 
14
conducting the clinical drug trial to disclose: (i) the name 
15
and U.S. patent number of the drug or drugs being used in the 
16
clinical drug trial and (ii) the result or results of the 
17
clinical drug trial.
18
    The information so gathered  shall be stored, categorized, 
19
and collected in a clinical trials data bank to be administered 
20
by the Department.  The Department shall ensure, at least 
21
annually, the publication of clinical trials data bank 
22
information with personal identifiers redacted and focusing on 
23
the aggregate data   collected and the results of the trials.  The 
24
purpose of publicizing data bank information  is  to provide 
25
relevant information about the drugs involved  to patients and 
26
physicians and to educate the public by providing relevant  
27
information  in language readily comprehensible by the general 
28
public. The Department shall undertake all steps necessary 
29
under State and federal law to protect patient confidentiality 
30
in order to prevent the identification of individual patients.
31
    The Department shall adopt rules as necessary to implement 
32
this Section pursuant to the Illinois Administrative Procedure 
 


 






SB1517
- 2 -
LRB094 08104 RSP 38289 b




1
Act.